HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Monk, P. N. Articles by Pease, J. E. Search for Related Content PubMed PubMed Citation Articles by Monk, P. N. Articles by Pease, J. E. Social Bookmarking                      What's this?

Volume 270, Number 28, Issue of July 14, pp. 16625-16629, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Peter N. Monk , Michael D. Barker , Lynda J. Partridge , James E. Pease

C5a, a potent chemoattractant for monocytes, neutrophils, and other leukocytes, binds to a cell surface receptor of the seven-transmembrane superfamily. Here we report the effects of substituting Gln for Glu of the human C5a receptor (hC5aR) expressed in a model cell system for chemoattractant receptor signaling, the rat basophilic leukemia cell line RBL-2H3. Both the binding affinity for hC5a and the EC for subsequent cellular signals are reduced 5-10-fold by this substitution. A peptide mimic of the C terminus of C5a also binds to, and activates, hC5aR. The response to this peptide is reduced in cells bearing mutated hC5aR, indicating that the mutation affects interactions with the C terminus of hC5a. The C-terminal peptide contains only two basic residues, a Lys and an Arg (assumed to be analogous to Lys and Arg of hC5a), which could act as counter-ions for Glu of the receptor. If the counter-ion on hC5a was Arg, then it would be expected that intact hC5a and hC5a des-Arg would have identical affinities and potencies when interacting with mutant hC5aR. It was found, however, that the binding affinity and potency (for receptor signaling events) of hC5a des-Arg was always lower than for intact hC5a. Furthermore, the equivalent C-terminal peptide to hC5a des-Arg (i.e. lacking the C-terminal Arg) could partially activate the wild type but not the mutant receptor, whereas the converse peptide, containing Arg but containing Met instead of Lys, had equal potencies for both wild type and mutant receptors. Taken together these data indicate that Glu of hC5aR is not involved in an interaction with Arg of hC5a, but may interact with Lys of hC5a. Mutation of Glu defines a second ligand binding site on hC5aR, distinct from the previously characterized site on the receptor N terminus. Unlike the N-terminal binding site, this second site is associated not just with the interaction with hC5a, but also with receptor activation.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. M. Waters, R. M. Brodbeck, J. Steflik, J. Yu, C. Baltazar, A. E. Peck, D. Severance, L. Y. Zhang, K. Currie, B. L. Chenard, et al. Molecular Characterization of the Gerbil C5a Receptor and Identification of a Transmembrane Domain V Amino Acid That Is Crucial for Small Molecule Antagonist Interaction J. Biol. Chem., December 9, 2005; 280(49): 40617 - 40623. [Abstract] [Full Text] [PDF]

				A. Higginbottom, S. A. Cain, T. M. Woodruff, L. M. Proctor, P. K. Madala, J. D. A. Tyndall, S. M. Taylor, D. P. Fairlie, and P. N. Monk Comparative Agonist/Antagonist Responses in Mutant Human C5a Receptors Define the Ligand Binding Site J. Biol. Chem., May 6, 2005; 280(18): 17831 - 17840. [Abstract] [Full Text] [PDF]

				M. S. Huber-Lang, J. V. Sarma, S. R. McGuire, K. T. Lu, V. A. Padgaonkar, E. M. Younkin, R. F. Guo, C. H. Weber, E. R. Zuiderweg, F. S. Zetoune, et al. Structure-Function Relationships of Human C5a and C5aR J. Immunol., June 15, 2003; 170(12): 6115 - 6124. [Abstract] [Full Text] [PDF]

				D. Kalant, S. A. Cain, M. Maslowska, A. D Sniderman, K. Cianflone, and P. N. Monk The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein J. Biol. Chem., March 21, 2003; 278(13): 11123 - 11129. [Abstract] [Full Text] [PDF]

				S. A. Cain and P. N. Monk The Orphan Receptor C5L2 Has High Affinity Binding Sites for Complement Fragments C5a and C5a des-Arg74 J. Biol. Chem., February 22, 2002; 277(9): 7165 - 7169. [Abstract] [Full Text] [PDF]

				S.A. Cain, D.M. Williams, V. Harris, and P.N. Monk Selection of novel ligands from a whole-molecule randomly mutated C5a library Protein Eng. Des. Sel., March 1, 2001; 14(3): 189 - 193. [Abstract] [Full Text] [PDF]

				T.-H. Chao, J. A. Ember, M. Wang, Y. Bayon, T. E. Hugli, and R. D. Ye Role of the Second Extracellular Loop of Human C3a Receptor in Agonist Binding and Receptor Function J. Biol. Chem., April 2, 1999; 274(14): 9721 - 9728. [Abstract] [Full Text] [PDF]

				T. Crass, R. S. Ames, H. M. Sarau, M. A. Tornetta, J. J. Foley, J. Kohl, A. Klos, and W. Bautsch Chimeric Receptors of the Human C3a Receptor and C5a Receptor (CD88) J. Biol. Chem., March 26, 1999; 274(13): 8367 - 8370. [Abstract] [Full Text] [PDF]

				H. Hawlisch, R. Frank, M. Hennecke, M. Baensch, B. Sohns, L. Arseniev, W. Bautsch, A. Kola, A. Klos, and J. Kohl Site-Directed C3a Receptor Antibodies from Phage Display Libraries J. Immunol., March 15, 1998; 160(6): 2947 - 2958. [Abstract] [Full Text] [PDF]